EGFR and breast cancer: Epidermal growth factor receptors, a subfamily of RTKs, are targeted by inhibitors and monoclonal antibodies which may prevent proliferation and angiogenesis in multiple cancer types, including breast cancer, colorectal cancer and lung cancer [38].